PLEASANTON, Calif., May 9, 2011 /PRNewswire/ — TriReme Medical,
Inc. (TriReme), a leading developer of innovative catheters and
stents for the treatment of complex vascular disease, announced
today the appointment of Mr. Supratim Bose and Mr. Michael Kleine
to their Board of Directors.
Mr. Bose, Founder and CEO of Bose Consulting Group, is based in
Singapore and was until recently Company Group Chairman at Johnson
& Johnson with responsibilities for all of the Medical Devices
& Diagnostics franchises across the Asia-Pacific Region.
Mr. Bose was also a member of the Worldwide Group Operating
Committee at Johnson & Johnson Medical Devices &
Diagnostics Group.
Mr. Kleine was previously President and CEO of Biosensors
International (SGX), a medical device company listed on the
Singapore Stock Exchange. He brings vast experience in
medical devices having held CEO and President positions at
Microvention, Thermo Cardiosystems, Sorin Biomedical and Bird
Medical.
“TriReme is developing an exciting range of innovative and
differentiated devices and I am excited to help lead their Asian
centered strategy,” commented Mr. Bose. Mr. Kleine added,
“TriReme has created a truly global vision and its expansion is
supported by a strong pipeline of unique products.”
“Supratim and Mike’s enormous experience with the Asian markets
provide an extended dimension to both our Board and management
teams. TriReme is honored to have the endorsement of both
industry veterans who support and share our global vision of
medtech growth and development in Asia,” said Eitan Konstantino,
PhD, President and Chief Executive Officer of TriReme.
About TriReme Medical, Inc.
Based in Pleasanton, California, TriReme Medical, Inc. is a
privately held medical device company dedicated to the development,
manufacturing, and commercialization of next generation
percutaneous devices for the treatment of complex coronary an
‘/>”/>
